Literature DB >> 3019642

Plasma catecholamines do not participate in pituitary-adrenal activation by immobilization stress in rats with transection of nerve fibers to the median eminence.

G B Makara, R Kvetnansky, D Jezova, A Jindra, I Kakucska, Z Oprsalova.   

Abstract

The effect of immobilization stress was studied in rats in which the CRF and arginine vasopressin-containing innervation of the median eminence was destroyed by an anterolateral cut (ALC) around the medial basal hypothalamus. One week after surgery, the rats with ALC were subjected to immobilization and they showed a normal rise in plasma corticosterone, a smaller than normal rise of plasma ACTH, and an increased response of plasma epinephrine and norepinephrine. When in rats with an ALC the response of plasma catecholamines was prevented by guanethidine pretreatment and adrenal enucleation the small rise in plasma ACTH was unchanged during immobilization. In addition, the plasma corticosterone and ACTH rises during immobilization in the rats with ALC were not influenced by prior treatment with phentolamine (2.5 mg/kg ip) or propranolol (2.5 mg/kg ip). These findings suggest that the large rises in plasma epinephrine and norepinephrine levels during immobilization do not contribute to changes in plasma ACTH or corticosterone levels when hypothalamic regulation via CRF and/or arginine vasopressin is interrupted by ALC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019642     DOI: 10.1210/endo-119-4-1757

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Beta-adrenergic receptors mediate a stress-induced decrease in IGF-II mRNA in the rat cerebellum.

Authors:  N Tritos; E Kitraki; H Phillipidis; F Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  1998-10       Impact factor: 5.046

2.  Interleukin 1 prevents loss of corticotropic responsiveness to beta-adrenergic stimulation in vitro.

Authors:  M Boyle; G Yamamoto; M Chen; J Rivier; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.